TI
IBB icon

tru Independence’s iShares Biotechnology ETF IBB Stock Holding History

tru Independence’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,746
Closed -$336K – 113
2023
Q3 		$336K Sell
2,746
-83
-3% -$10.6K 0.12% 96
2023
Q2 		$359K Sell
2,829
-138
-5% -$17.9K 0.12% 88
2023
Q1 		$383K Sell
2,967
-464
-14% -$60.7K 0.12% 90
2022
Q4 		$450K Sell
3,431
-49
-1% -$6.33K 0.15% 86
2022
Q3 		$407K Sell
3,480
-230
-6% -$28.6K 0.14% 85
2022
Q2 		$436K Sell
3,710
-424
-10% -$50.3K 0.14% 94
2022
Q1 		$539K Sell
4,134
-33
-0.8% -$4.3K 0.15% 96
2021
Q4 		$636K Sell
4,167
-56
-1% -$8.67K 0.17% 89
2021
Q3 		$683K Buy
+4,223
New +$711K 0.19% 84
2021
Q2 		– Sell
-4,617
Closed -$695K – 317
2021
Q1 		$695K Buy
+4,617
New +$733K 0.13% 150
2020
Q4 		– Sell
-77
Closed -$10K – 786
2020
Q3 		$10K Buy
+77
New +$10.4K ﹤0.01% 279
2020
Q1 		– Sell
-79,883
Closed -$8.61M – 791
2019
Q4 		$8.61M Buy
+79,883
New +$8.91M 1.24% 23

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

tru Independence's IBB Position: Q4 2023 in Review

tru Independence sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 2,746 shares — an estimated $336K sold.

tru Independence first reported a position in IBB in Q4 2019 and held it in 12 quarters. The position peaked at $8.61M in Q4 2019. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

  • tru Independence reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
  • tru Independence sold 2,746 iShares Biotechnology ETF shares in Q4 2023, an estimated $336K.
  • tru Independence first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 12 quarters.
  • tru Independence's iShares Biotechnology ETF position peaked at $8.61M in Q4 2019.
  • 872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on tru Independence's 13F filing for Q4 2023, filed 10 Jan 2024.